{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:06:46Z","timestamp":1782504406784,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G090118N"],"award-info":[{"award-number":["G090118N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G0E7520N"],"award-info":[{"award-number":["G0E7520N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G081821N"],"award-info":[{"award-number":["G081821N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G094522N"],"award-info":[{"award-number":["G094522N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["W0.014.22N"],"award-info":[{"award-number":["W0.014.22N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007229","name":"Bijzonder Onderzoeksfonds","doi-asserted-by":"publisher","award":["C14\/19\/099"],"award-info":[{"award-number":["C14\/19\/099"]}],"id":[{"id":"10.13039\/501100007229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Intracellular Ca\n                    <jats:sup>2+<\/jats:sup>\n                    signals control several physiological and pathophysiological processes. The main tool to chelate intracellular Ca\n                    <jats:sup>2+<\/jats:sup>\n                    is intracellular BAPTA (BAPTA\n                    <jats:sub>i<\/jats:sub>\n                    ), usually introduced into cells as a membrane-permeant acetoxymethyl ester (BAPTA-AM). Previously, we demonstrated that BAPTA\n                    <jats:sub>i<\/jats:sub>\n                    enhanced apoptosis induced by venetoclax, a BCL-2 antagonist, in diffuse large B-cell lymphoma (DLBCL). This finding implied a novel interplay between intracellular Ca\n                    <jats:sup>2+<\/jats:sup>\n                    signaling and anti-apoptotic BCL-2 function. Hence, we set out to identify the underlying mechanisms by which BAPTA\n                    <jats:sub>i<\/jats:sub>\n                    enhances cell death in B-cell cancers. In this study, we discovered that BAPTA\n                    <jats:sub>i<\/jats:sub>\n                    alone induced apoptosis in hematological cancer cell lines that were highly sensitive to S63845, an MCL-1 antagonist. BAPTA\n                    <jats:sub>i<\/jats:sub>\n                    provoked a rapid decline in MCL-1-protein levels by inhibiting mTORC1-driven\n                    <jats:italic>Mcl-1<\/jats:italic>\n                    translation. These events were not a consequence of cell death, as BAX\/BAK-deficient cancer cells exhibited similar downregulation of mTORC1 activity and MCL-1-protein levels. Next, we investigated how BAPTA\n                    <jats:sub>i<\/jats:sub>\n                    diminished mTORC1 activity and identified its ability to impair glycolysis by directly inhibiting 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase 3 (PFKFB3) activity, a previously unknown effect of BAPTA\n                    <jats:sub>i<\/jats:sub>\n                    . Notably, these effects were also induced by a BAPTA\n                    <jats:sub>i<\/jats:sub>\n                    analog with low affinity for Ca\n                    <jats:sup>2+<\/jats:sup>\n                    . Consequently, our findings uncover PFKFB3 inhibition as an Ca\n                    <jats:sup>2+<\/jats:sup>\n                    -independent mechanism through which BAPTA\n                    <jats:sub>i<\/jats:sub>\n                    impairs cellular metabolism and ultimately compromises the survival of MCL-1-dependent cancer cells. These findings hold two important implications. Firstly, the direct inhibition of PFKFB3 emerges as a key regulator of mTORC1 activity and a promising target in MCL-1-dependent cancers. Secondly, cellular effects caused by BAPTA\n                    <jats:sub>i<\/jats:sub>\n                    are not necessarily related to Ca\n                    <jats:sup>2+<\/jats:sup>\n                    signaling. Our data support the need for a reassessment of the role of Ca\n                    <jats:sup>2+<\/jats:sup>\n                    in cellular processes when findings were based on the use of BAPTA\n                    <jats:sub>i<\/jats:sub>\n                    .\n                  <\/jats:p>","DOI":"10.1038\/s41419-023-06120-4","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T01:01:47Z","timestamp":1694134907000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Intracellular BAPTA directly inhibits PFKFB3, thereby impeding mTORC1-driven Mcl-1 translation and killing MCL-1-addicted cancer cells"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0329-7973","authenticated-orcid":false,"given":"Flore","family":"Sneyers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2497-9244","authenticated-orcid":false,"given":"Martijn","family":"Kerkhofs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke","family":"Speelman-Rooms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Welkenhuyzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"La Rovere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Shemy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnout","family":"Voet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3354-5819","authenticated-orcid":false,"given":"Guy","family":"Eelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0382-9346","authenticated-orcid":false,"given":"Mieke","family":"Dewerchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7697-132X","authenticated-orcid":false,"given":"Stephen W. G.","family":"Tait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Ghesqui\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6447-3451","authenticated-orcid":false,"given":"Martin D.","family":"Bootman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5968-4828","authenticated-orcid":false,"given":"Geert","family":"Bultynck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,8]]},"reference":[{"key":"6120_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/35036035","volume":"1","author":"M Berridge","year":"2000","unstructured":"Berridge M, Lipp P, Bootman M. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 2000;1:11\u201321.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6120_CR2","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.cell.2007.11.028","volume":"131","author":"D Clapham","year":"2007","unstructured":"Clapham D. Calcium signaling. Cell. 2007;131:1047\u201358.","journal-title":"Cell"},{"key":"6120_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrc.2017.18","volume":"17","author":"G Monteith","year":"2017","unstructured":"Monteith G, Prevarskaya N, Roberts-Thomson S. The calcium-cancer signalling nexus. Nat Rev Cancer. 2017;17:367\u201380.","journal-title":"Nat Rev Cancer"},{"key":"6120_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coph.2016.03.002","volume":"29","author":"S Marchi","year":"2016","unstructured":"Marchi S, Pinton P. Alterations of calcium homeostasis in cancer cells. Curr Opin Pharmacol. 2016;29:1\u20136.","journal-title":"Curr Opin Pharmacol"},{"key":"6120_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.bbcan.2012.12.001","volume":"1835","author":"H Akl","year":"2013","unstructured":"Akl H, Bultynck G. Altered Ca2+ signaling in cancer cells: proto-oncogenes and tumor suppressors targeting IP3 receptors. Biochim Biophys Acta Rev Cancer. 2013;1835:180\u201393.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"6120_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jbior.2017.12.001","volume":"68","author":"H Ando","year":"2018","unstructured":"Ando H, Kawaai K, Bonneau B, Mikoshiba K. Remodeling of Ca 2+ signaling in cancer: regulation of inositol 1,4,5-trisphosphate receptors through oncogenes and tumor suppressors. Adv Biol Regul. 2018;68:64\u201376.","journal-title":"Adv Biol Regul"},{"key":"6120_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.bbamcr.2011.11.018","volume":"1823","author":"S Grimm","year":"2012","unstructured":"Grimm S. The ER-mitochondria interface: the social network of cell death. Biochim Biophys Acta. 2012;1823:327\u201334.","journal-title":"Biochim Biophys Acta"},{"key":"6120_CR8","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41418-021-00894-w","volume":"29","author":"N Rosa","year":"2022","unstructured":"Rosa N, Ivanova H, Wagner LE, Kale J, La Rovere R, Welkenhuyzen K, et al. Bcl-xL acts as an inhibitor of IP 3 R channels, thereby antagonizing Ca 2+-driven apoptosis. Cell Death Differ. 2022;29:788\u2013805.","journal-title":"Cell Death Differ"},{"key":"6120_CR9","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.tcb.2013.08.003","volume":"23","author":"K Sarosiek","year":"2013","unstructured":"Sarosiek K, Ni Chonghaile T, Letai A. Mitochondria: gatekeepers of response to chemotherapy. Trends Cell Biol. 2013;23:612\u201319.","journal-title":"Trends Cell Biol"},{"key":"6120_CR10","doi-asserted-by":"publisher","unstructured":"Vandenabeele P, Bultynck G, Savvides SN. Pore-forming proteins as drivers of membrane permeabilization in cell death pathways. Nat Rev Mol Cell Biol. 2023;24. https:\/\/doi.org\/10.1038\/S41580-022-00564-W.","DOI":"10.1038\/S41580-022-00564-W"},{"key":"6120_CR11","doi-asserted-by":"publisher","unstructured":"Green DR. The mitochondrial pathway of apoptosis: part I: MOMP and beyond. Cold Spring Harb Perspect Biol. 2022;14. https:\/\/doi.org\/10.1101\/CSHPERSPECT.A041038.","DOI":"10.1101\/CSHPERSPECT.A041038"},{"key":"6120_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","volume":"21","author":"FJ Bock","year":"2020","unstructured":"Bock FJ, Tait SWG. Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol. 2020;21:85\u2013100.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6120_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/cdd.2016.105","volume":"24","author":"V Peperzak","year":"2017","unstructured":"Peperzak V, Slinger E, Ter Burg J, Eldering E. Functional disparities among BCL-2 members in tonsillar and leukemic B-cell subsets assessed by BH3-mimetic profiling. Cell Death Differ. 2017;24:111\u201319.","journal-title":"Cell Death Differ"},{"key":"6120_CR14","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1080\/10428194.2017.1283032","volume":"58","author":"P Bose","year":"2017","unstructured":"Bose P, Gandhi V, Konopleva M. Pathways and mechanisms of venetoclax resistance. Leuk Lymphoma. 2017;58:2026\u201339.","journal-title":"Leuk Lymphoma"},{"key":"6120_CR15","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/s41418-019-0391-9","volume":"27","author":"M Villalobos-Ortiz","year":"2020","unstructured":"Villalobos-Ortiz M, Ryan J, Mashaka TN, Opferman JT, Letai A. BH3 profiling discriminates on-target small molecule BH3 mimetics from putative mimetics. Cell Death Differ. 2020;27:999.","journal-title":"Cell Death Differ"},{"key":"6120_CR16","doi-asserted-by":"publisher","unstructured":"Kehr S, Vogler M. It\u2019s time to die: BH3 mimetics in solid tumors. Biochim Biophys Acta Mol Cell Res. 2021;1868. https:\/\/doi.org\/10.1016\/J.BBAMCR.2021.118987.","DOI":"10.1016\/J.BBAMCR.2021.118987"},{"key":"6120_CR17","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.bbamcr.2016.11.024","volume":"1864","author":"T Vervloessem","year":"2017","unstructured":"Vervloessem T, Ivanova H, Luyten T, Parys JB, Bultynck G. The selective Bcl-2 inhibitor venetoclax, a BH3 mimetic, does not dysregulate intracellular Ca2+ signaling. Biochim Biophys Acta Mol Cell Res. 2017;1864:968\u201376.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"6120_CR18","doi-asserted-by":"publisher","unstructured":"Smith NA, Kress BT, Lu Y, Chandler-Militello D, Benraiss A, Nedergaard M. Fluorescent Ca2+ indicators directly inhibit the Na,K-ATPase and disrupt cellular functions. Sci Signal. 2018;11. https:\/\/doi.org\/10.1126\/scisignal.aal2039.","DOI":"10.1126\/scisignal.aal2039"},{"key":"6120_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ceca.2018.04.005","volume":"73","author":"MD Bootman","year":"2018","unstructured":"Bootman MD, Allman S, Rietdorf K, Bultynck G. Deleterious effects of calcium indicators within cells; an inconvenient truth. Cell Calcium. 2018;73:82\u20137.","journal-title":"Cell Calcium"},{"key":"6120_CR20","doi-asserted-by":"publisher","unstructured":"Lopez J, Bessou M, Riley JS, Giampazolias E, Todt F, Rocheg\u00fce T, et al. Mito-priming as a method to engineer Bcl-2 addiction. Nat Commun. 2016;7. https:\/\/doi.org\/10.1038\/NCOMMS10538.","DOI":"10.1038\/NCOMMS10538"},{"key":"6120_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41418-018-0142-3","volume":"26","author":"M Bittremieux","year":"2019","unstructured":"Bittremieux M, Rovere RML, Akl H, Martines C, Welkenhuyzen K, Dubron K, et al. Constitutive IP3 signaling underlies the sensitivity of B-cell cancers to the Bcl-2\/IP3 receptor disruptor BIRD-2. Cell Death Differ. 2019;26:531.","journal-title":"Cell Death Differ"},{"key":"6120_CR22","doi-asserted-by":"publisher","unstructured":"Cerella C, Muller F, Gaigneaux A, Radogna F, Viry E, Chateauvieux S, et al. Early downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450. Cell Death Dis. 2015;6. https:\/\/doi.org\/10.1038\/CDDIS.2015.134.","DOI":"10.1038\/CDDIS.2015.134"},{"key":"6120_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/cdd.2011.97","volume":"19","author":"G Monaco","year":"2012","unstructured":"Monaco G, Decrock E, Akl H, Ponsaerts R, Vervliet T, Luyten T, et al. Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl. Cell Death Differ. 2012;19:295\u2013309.","journal-title":"Cell Death Differ"},{"key":"6120_CR24","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.4161\/auto.7.12.17909","volume":"7","author":"J-P Decuypere","year":"2011","unstructured":"Decuypere J-P, Welkenhuyzen K, Luyten T, Ponsaerts R, Dewaele M, Molg\u00f3 J, et al. Ins(1,4,5)P3 receptor-mediated Ca2+ signaling and autophagy induction are interrelated. Autophagy. 2011;7:1472.","journal-title":"Autophagy"},{"key":"6120_CR25","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1021\/acs.jmedchem.5b00352","volume":"58","author":"S Boyd","year":"2015","unstructured":"Boyd S, Brookfield JL, Critchlow SE, Cumming IA, Curtis NJ, Debreczeni J, et al. Structure-based design of potent and selective inhibitors of the metabolic kinase PFKFB3. J Med Chem. 2015;58:3611\u201325.","journal-title":"J Med Chem"},{"key":"6120_CR26","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/prot.24015","volume":"80","author":"MC Cavalier","year":"2012","unstructured":"Cavalier MC, Kim SG, Neau D, Lee YH. Molecular basis of the fructose-2,6-bisphosphatase reaction of PFKFB3: transition state and the C-terminal function. Proteins. 2012;80:1143.","journal-title":"Proteins"},{"key":"6120_CR27","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","volume":"267","author":"G Jones","year":"1997","unstructured":"Jones G, Willett P, Glen RC, Leach AR, Taylor R. Development and validation of a genetic algorithm for flexible docking. J Mol Biol. 1997;267:727\u201348.","journal-title":"J Mol Biol"},{"key":"6120_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2010.38","volume":"1","author":"M Fricker","year":"2010","unstructured":"Fricker M, O\u2019Prey J, Tolkovsky AM, Ryan KM. Phosphorylation of Puma modulates its apoptotic function by regulating protein stability. Cell Death Dis. 2010;1:e59.","journal-title":"Cell Death Dis"},{"key":"6120_CR29","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature19830","volume":"538","author":"A Kotschy","year":"2016","unstructured":"Kotschy A, Szlavik Z, Murray J, Davidson J, Maragno A, Le Toumelin-Braizat G, et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature. 2016;538:477\u201382.","journal-title":"Nature"},{"key":"6120_CR30","doi-asserted-by":"publisher","first-page":"30039","DOI":"10.1074\/jbc.M109.039545","volume":"284","author":"H Masuoka","year":"2009","unstructured":"Masuoka H, Mott J, Bronk S, Werneburg N, Akazawa Y, Kaufmann S, et al. Mcl-1 degradation during hepatocyte lipoapoptosis. J Biol Chem. 2009;284:30039\u201348.","journal-title":"J Biol Chem"},{"key":"6120_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrm2672","volume":"10","author":"XM Ma","year":"2009","unstructured":"Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol. 2009;10:307\u201318.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6120_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sigtrans.2017.44","volume":"2","author":"L Shi","year":"2017","unstructured":"Shi L, Pan H, Liu Z, Xie J, Han W. Roles of PFKFB3 in cancer. Signal Transduct Target Ther. 2017;2:1\u201310.","journal-title":"Signal Transduct Target Ther"},{"key":"6120_CR33","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1016\/j.atherosclerosis.2020.10.266","volume":"315","author":"C Savva","year":"2020","unstructured":"Savva C, Gonz Alez-Granillo M, Li X, Angelin B, Korach-Andr M, Modder M, et al. 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase-3 (PFKFB3). Atherosclerosis. 2020;315:e87.","journal-title":"Atherosclerosis"},{"key":"6120_CR34","doi-asserted-by":"publisher","unstructured":"De Bock K, Georgiadou M, Schoors S, Kuchnio A, Wong B, Cantelmo A, et al. Role of PFKFB3-driven glycolysis in vessel sprouting. Cell. 2013;154. https:\/\/doi.org\/10.1016\/J.CELL.2013.06.037.","DOI":"10.1016\/J.CELL.2013.06.037"},{"key":"6120_CR35","doi-asserted-by":"publisher","unstructured":"Burmistrova O, Olias-Arjona A, Lapresa R, Jimenez-Blasco D, Eremeeva T, Shishov D, et al. Targeting PFKFB3 alleviates cerebral ischemia-reperfusion injury in mice. Sci Rep. 2019;9. https:\/\/doi.org\/10.1038\/S41598-019-48196-Z.","DOI":"10.1038\/S41598-019-48196-Z"},{"key":"6120_CR36","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nature02067","volume":"426","author":"JT Opferman","year":"2003","unstructured":"Opferman JT, Letai A, Beard C, Sorcinelli MD, Ong CC, Korsmeyer SJ. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature. 2003;426:671\u20136.","journal-title":"Nature"},{"key":"6120_CR37","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1158\/2159-8290.CD-18-0140","volume":"8","author":"HE Ramsey","year":"2018","unstructured":"Ramsey HE, Fischer MA, Lee T, Gorska AE, Arrate MP, Fuller L, et al. A novel MCL-1 inhibitor combined with venetoclax rescues venetoclax-resistant acute myelogenous leukemia. Cancer Discov. 2018;8:1566.","journal-title":"Cancer Discov"},{"key":"6120_CR38","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ccr.2006.10.006","volume":"10","author":"M Konopleva","year":"2006","unstructured":"Konopleva M, Contractor R, Tsao T, Samudio I, Ruvolo P, Kitada S, et al. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell. 2006;10:375\u201388.","journal-title":"Cancer Cell"},{"key":"6120_CR39","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/ejh.13492","volume":"105","author":"M Hormi","year":"2020","unstructured":"Hormi M, Birsen R, Belhadj M, Huynh T, Cantero Aguilar L, Grignano E, et al. Pairing MCL-1 inhibition with venetoclax improves therapeutic efficiency of BH3-mimetics in AML. Eur J Haematol. 2020;105:588\u201396.","journal-title":"Eur J Haematol"},{"key":"6120_CR40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ccr.2006.08.027","volume":"10","author":"M van Delft","year":"2006","unstructured":"van Delft M, Wei A, Mason K, Vandenberg C, Chen L, Czabotar P, et al. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak\/Bax if Mcl-1 is neutralized. Cancer Cell. 2006;10:389\u201399.","journal-title":"Cancer Cell"},{"key":"6120_CR41","doi-asserted-by":"publisher","unstructured":"Birkinshaw R, Gong J, Luo C, Lio D, White C, Anderson M, et al. Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations. Nat Commun. 2019;10. https:\/\/doi.org\/10.1038\/S41467-019-10363-1.","DOI":"10.1038\/S41467-019-10363-1"},{"key":"6120_CR42","doi-asserted-by":"publisher","first-page":"E434","DOI":"10.3324\/haematol.2019.222588","volume":"104","author":"E Tausch","year":"2019","unstructured":"Tausch E, Close W, Dolnik A, Bloehdorn J, Chyla B, Bullinger L, et al. Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia. Haematologica. 2019;104:E434\u20137.","journal-title":"Haematologica"},{"key":"6120_CR43","doi-asserted-by":"publisher","unstructured":"Tarantelli C, Gaudio E, Hillmann P, Spriano F, Sartori G, Aresu L, et al. The novel TORC1\/2 kinase inhibitor PQR620 has anti-tumor activity in lymphomas as a single agent and in combination with venetoclax. Cancers. 2019;11. https:\/\/doi.org\/10.3390\/CANCERS11060775.","DOI":"10.3390\/CANCERS11060775"},{"key":"6120_CR44","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/bjh.15079","volume":"184","author":"H Jiang","year":"2019","unstructured":"Jiang H, Lwin T, Zhao X, Ren Y, Li G, Moscinski L, et al. Venetoclax as a single agent and in combination with PI3K-MTOR1\/2 kinase inhibitors against ibrutinib sensitive and resistant mantle cell lymphoma (MCL). Br J Haematol. 2019;184:298.","journal-title":"Br J Haematol"},{"key":"6120_CR45","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3389\/fonc.2018.00556","volume":"8","author":"JE Ricci","year":"2018","unstructured":"Ricci JE, Chiche J. Metabolic reprogramming of non-Hodgkin\u2019s B-cell lymphomas and potential therapeutic strategies. Front Oncol. 2018;8:556.","journal-title":"Front Oncol"},{"key":"6120_CR46","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1038\/s41418-018-0244-y","volume":"26","author":"M Tailler","year":"2019","unstructured":"Tailler M, Lindqvist LM, Gibson L, Adams JM. By reducing global mRNA translation in several ways, 2-deoxyglucose lowers MCL-1 protein and sensitizes hemopoietic tumor cells to BH3 mimetic ABT737. Cell Death Differ. 2019;26:1766.","journal-title":"Cell Death Differ"},{"key":"6120_CR47","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.isci.2019.09.040","volume":"20","author":"E Almacellas","year":"2019","unstructured":"Almacellas E, Pelletier J, Manzano A, Gentilella A, Ambrosio S, Mauvezin C, et al. Phosphofructokinases axis controls glucose-dependent mTORC1 activation driven by E2F1. iScience. 2019;20:434\u201348.","journal-title":"iScience"},{"key":"6120_CR48","doi-asserted-by":"publisher","first-page":"11528","DOI":"10.1016\/S0021-9258(19)50232-0","volume":"268","author":"A Richardson","year":"1993","unstructured":"Richardson A, Taylor CW. Effects of Ca2+ chelators on purified inositol 1,4,5-trisphosphate (InsP3) receptors and InsP3-stimulated Ca2+ mobilization. J Biol Chem. 1993;268:11528\u201333.","journal-title":"J Biol Chem"},{"key":"6120_CR49","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1016\/j.bbamem.2007.07.003","volume":"1768","author":"V Sabanov","year":"2007","unstructured":"Sabanov V, Nedergaard J. Ca(2+) -independent effects of BAPTA and EGTA on single-channel Cl(-) currents in brown adipocytes. Biochim Biophys Acta. 2007;1768:2714\u201325.","journal-title":"Biochim Biophys Acta"},{"key":"6120_CR50","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1111\/j.1432-1033.2004.04259.x","volume":"271","author":"Y Saoudi","year":"2004","unstructured":"Saoudi Y, Rousseau B, Doussi\u00e8re J, Charrasse S, Gauthier-Rouvi\u00e8re C, Morin N, et al. Calcium-independent cytoskeleton disassembly induced by BAPTA. Eur J Biochem. 2004;271:3255\u201364.","journal-title":"Eur J Biochem"},{"key":"6120_CR51","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1126\/science.1065693","volume":"295","author":"Y Matsumoto","year":"2002","unstructured":"Matsumoto Y, Maller JL. Calcium, calmodulin, and CaMKII requirement for initiation of centrosome duplication in Xenopus egg extracts. Science. 2002;295:499\u2013502.","journal-title":"Science"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06120-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06120-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06120-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T01:02:04Z","timestamp":1694134924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06120-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,8]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["6120"],"URL":"https:\/\/doi.org\/10.1038\/s41419-023-06120-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1734783\/v1","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,8]]},"assertion":[{"value":"18 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"600"}}